LNG Butanoate + Testosterone Buciclate
LB + TB IM Injection
- User: Male
- Hormonal: Hormonal
-
Delivery type:
- Injectable
-
Intended Duration:
- Short-Acting
- Development Stage: Pre-Clinical
- Developer(s)/researcher(s): WHO Collaborating Center, India, India Institute of Medical Sciences, India Council of Medical Research
Details
- API: Levonorgestrel Butanoate, Testosterone Buciclate
- Target: Progesterone Receptor, Androgen Receptor
-
Mechanism of Action:
- Reduced Sperm Production
- Inactive Materials: Undetermined
- Regimen: 1 Injection/6 Months
- MPT: Not Potential MPT
Product Status
No additional publications indicating recent development since 2007
History
1995: Animal studies suggest LB viability as a male contraceptive method
2000-2007: Animal studies suggest LB viability as a male contraceptive method in combination with testosterone buciclate.